Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
07 07 2020
Historique:
received: 24 04 2020
accepted: 06 07 2020
pubmed: 8 7 2020
medline: 22 8 2020
entrez: 8 7 2020
Statut: epublish

Résumé

Understanding temporal dynamics of COVID-19 symptoms could provide fine-grained resolution to guide clinical decision-making. Here, we use deep neural networks over an institution-wide platform for the augmented curation of clinical notes from 77,167 patients subjected to COVID-19 PCR testing. By contrasting Electronic Health Record (EHR)-derived symptoms of COVID-19-positive (COVID

Identifiants

pubmed: 32633720
doi: 10.7554/eLife.58227
pii: 58227
pmc: PMC7410498
doi:
pii:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Institute of Allergy and Infectious Diseases
ID : AI110173
Pays : International
Organisme : National Institute of Allergy and Infectious Diseases
ID : AI120698
Pays : International
Organisme : NIAID NIH HHS
ID : R01 AI110173
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI120698
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : AI 110173
Pays : International

Informations de copyright

© 2020, Wagner et al.

Déclaration de conflit d'intérêts

TW, KM, SA, AV, SB, AP, MK, PA, ML, ZD, ES, HS, AA, RB, VS is an employee of nference and has financial interests in the company. FS, BP, JO, PB, RR, PV, ZT, SR, MM, WW, DC, GG, AW, WM, JH, AB has a Financial Conflict of Interest in technology used in the research and with Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies.

Références

mSystems. 2020 Jul 21;5(4):
pubmed: 32694130
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
N Engl J Med. 2020 May 28;382(22):2158-2160
pubmed: 32329972
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Elife. 2020 May 28;9:
pubmed: 32463365
Bioinformatics. 2020 Feb 15;36(4):1234-1240
pubmed: 31501885
Elife. 2020 May 26;9:
pubmed: 32452762
Nat Med. 2020 Jul;26(7):1037-1040
pubmed: 32393804
N Engl J Med. 2020 Mar 26;382(13):1278-1280
pubmed: 32069388
Gastroenterology. 2020 May;158(6):1831-1833.e3
pubmed: 32142773
BMJ. 2020 May 29;369:m1996
pubmed: 32471884
Nat Med. 2020 Apr;26(4):502-505
pubmed: 32284613

Auteurs

Tyler Wagner (T)

nference, Cambridge, United States.

Fnu Shweta (F)

Mayo Clinic, Rochester, United States.

Karthik Murugadoss (K)

nference, Cambridge, United States.

Samir Awasthi (S)

nference, Cambridge, United States.

A J Venkatakrishnan (AJ)

nference, Cambridge, United States.

Sairam Bade (S)

nference Labs, Bangalore, India.

Arjun Puranik (A)

nference, Cambridge, United States.

Martin Kang (M)

nference, Cambridge, United States.

Brian W Pickering (BW)

Mayo Clinic, Rochester, United States.

John C O'Horo (JC)

Mayo Clinic, Rochester, United States.

Philippe R Bauer (PR)

Mayo Clinic, Rochester, United States.

Raymund R Razonable (RR)

Mayo Clinic, Rochester, United States.

Paschalis Vergidis (P)

Mayo Clinic, Rochester, United States.

Zelalem Temesgen (Z)

Mayo Clinic, Rochester, United States.

Stacey Rizza (S)

Mayo Clinic, Rochester, United States.

Maryam Mahmood (M)

Mayo Clinic, Rochester, United States.

Walter R Wilson (WR)

Mayo Clinic, Rochester, United States.

Douglas Challener (D)

Mayo Clinic, Rochester, United States.

Praveen Anand (P)

nference Labs, Bangalore, India.

Matt Liebers (M)

nference, Cambridge, United States.

Zainab Doctor (Z)

nference, Cambridge, United States.

Eli Silvert (E)

nference, Cambridge, United States.

Hugo Solomon (H)

nference, Cambridge, United States.

Akash Anand (A)

nference Labs, Bangalore, India.

Rakesh Barve (R)

nference Labs, Bangalore, India.

Gregory Gores (G)

Mayo Clinic, Rochester, United States.

Amy W Williams (AW)

Mayo Clinic, Rochester, United States.

William G Morice (WG)

Mayo Clinic, Rochester, United States.
Mayo Clinic Laboratories, Rochester, United States.

John Halamka (J)

Mayo Clinic, Rochester, United States.

Andrew Badley (A)

Mayo Clinic, Rochester, United States.

Venky Soundararajan (V)

nference, Cambridge, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH